The aberrant expression of ACE2 in these tumors raises concerns regarding the susceptibility of cancer patients to SARS‐CoV‐2 infection, as higher ACE2 levels could facilitate viral entry into host cells (Figure 1). Here, ACE2 is linked to cancer.